|
Market Closed -
Nasdaq
01:30:00 18/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.700 USD | +0.75% |
|
0.00% | +65.64% |
| 14/08 | Ovid Therapeutics Reports Pipeline and Business Updates | CI |
| 13/08 | Ovid Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 52Cr 46Cr 43Cr 39Cr 73Cr 5.02TCr 74Cr 513.78Cr 198.59Cr 2.55TCr 196.55Cr 192.22Cr 8.17TCr | P/E 2026 * |
-7.28x | P/E 2027 * | -6.62x |
|---|---|---|---|---|---|
| Enterprise Value | 52Cr 46Cr 43Cr 39Cr 73Cr 5.02TCr 74Cr 513.78Cr 198.59Cr 2.55TCr 196.55Cr 192.22Cr 8.17TCr | EV / Sales 2026 * |
639x | EV / Sales 2027 * | 2,344x |
| Free-Float |
93.28% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OVID | Delayed | |
CBOE
| OVID | Real-time | |
|
Deutsche Boerse AG
| 1OT | Delayed | |
|
Börse Stuttgart
| 1OT | Delayed | |
|
Boerse Muenchen
| 1OT | Real-time | |
|
Tradegate
| 1OT | Real-time |
Last Transcript: Ovid Therapeutics Inc.
| 1 day | +0.75% | ||
| Current month | +1.12% | ||
| 1 month | -4.59% | ||
| 3 months | +14.41% | ||
| 6 months | +38.46% | ||
| Current year | +65.64% |
| 1 week | 2.63 |  | 2.8 |
| 1 month | 2.61 | | 2.95 |
| Current year | 1.36 | | 3.1 |
| 1 year | 1.12 | | 3.1 |
| 3 years | 0.24 | | 4.1 |
| 5 years | 0.24 | | 4.14 |
| 10 years | 0.24 | | 15.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 01/01/2026 | |
Charles Carter
DFI | Director of Finance/CFO | 59 | 06/07/2026 |
Petra Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 60 | 02/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeremy Levin
CHM | Chairman | 72 | 01/04/2014 |
Bart Friedman
BRD | Director/Board Member | 81 | 23/11/2015 |
Barbara Duncan
BRD | Director/Board Member | 61 | 14/06/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/07/26 | Free | Chief Financial Officer | 50,000 | 0.0268% | ||
| 06/07/26 | Other | Chief Financial Officer | 4,50,625 | 0.2414% | ||
| 07/04/26 | Free | Director | 17,578 | 0.0133% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.75% | 0.00% | +136.84% | -31.99% | 52Cr | |
| +1.76% | +3.62% | +49.92% | +101.12% | 6.97TCr | |
| +2.29% | +0.32% | +37.65% | +77.03% | 6.12TCr | |
| +1.14% | -3.74% | -14.35% | +365.92% | 2.68TCr | |
| +0.32% | +2.58% | +29.26% | +14.12% | 2.61TCr | |
| +2.95% | +0.54% | -0.60% | -12.74% | 2.41TCr | |
| +1.49% | +5.15% | +26.46% | -15.89% | 2.04TCr | |
| -0.83% | -11.15% | +169.70% | +295.44% | 1.57TCr | |
| +3.01% | +0.27% | +49.44% | +168.18% | 1.41TCr | |
| +0.17% | -4.07% | -9.71% | +484.05% | 1.4TCr | |
| Average | +1.30% | -1.14% | +47.46% | +144.52% | 2.73TCr | |
| Weighted average by Cap. | +1.60% | +0.20% | +36.64% | +128.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8L 7L 7L 6L 11.46L 7.86Cr 11.52L 80.4L 31.08L 3.99Cr 30.76L 30.08L 13Cr | 2L 2L 2L 2L 3L 2.14Cr 3L 21.92L 8L 1.09Cr 8L 8L 3.48Cr |
| Net income | -6.83Cr -5.95Cr -5.63Cr -5.11Cr -9.55Cr -655.23Cr -9.61Cr -67Cr -26Cr -332.34Cr -26Cr -25Cr -1.07TCr | -8.48Cr -7.39Cr -6.99Cr -6.35Cr -12Cr -813.16Cr -12Cr -83Cr -32Cr -412.45Cr -32Cr -31Cr -1.32TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | $2.700 | +0.75% | 19,85,776 |
| 16/26/16 | $2.680 | -1.11% | 14,28,324 |
| 15/26/15 | $2.710 | -1.09% | 9,88,551 |
| 14/26/14 | $2.740 | +1.86% | 11,99,520 |
| 11/26/11 | $2.690 | +2.28% | 11,47,532 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OVID Stock
Select your edition
All financial news and data tailored to specific country editions
